• Exchange: OTC BB
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Boston Therapeutics Inc

+ Add to Watchlist

BTHE:US

0.5688 USD 0.0488 9.38%

As of 17:20:00 ET on 07/10/2014.

Snapshot for Boston Therapeutics Inc (BTHE)

Open: 0.5699 Day's Range: 0.5688 - 0.5699 Volume: 6,675
Previous Close: 0.5200 52wk Range: 0.1500 - 1.6700 1-Yr Rtn: +32.28%

Stock Chart for BTHE

No chart data available.
  • BTHE:US 0.5688
  • 1D
  • 1M
  • 1Y
0.5200
Interactive BTHE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTHE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 21.83
Shares Outstanding (M) 38.38
30 Day Average Volume 34,917
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTHE

No data available

Company Profile & Key Executives for BTHE

Boston Therapeutics Inc., is a pharmaceutical company. The Company develops, manufactures, and commercializes novel compounds for the treatment of diabetes and inflammatory diseases.

David PlattChairman/CEOKen TasseyPresident/Co-Founder
Anthony D SquegliaChief Financial OfficerJonathan B RomeChief Operating Officer
More Company Profile & Key Executives for BTHE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil